Venous Thromboembolism Treatment Market

Venous Thromboembolism Treatment Market: US Remains the Front Runner Driven by Favorable Reimbursement Scenario: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029

  • 2019-05-13
  • REP-GB-1341
  • 54 Tables
  • 114 Figures
  • 243 pages
  • PDF PPT EXCEL
 Venous Thromboembolism Treatment Market
  • SELECT LICENSE :

  • US$5,000
  • US$7,500
  • US$10,000

Venous Thromboembolism Treatment – Devices Used for Deep Venous Thrombosis and Pulmonary Embolism Treatments

The demand for venous thromboembolism treatment devices is expected to increase due to the increasing prevalence of pulmonary embolism. Venous thromboembolism are formation of thrombus in the deep veins specifically in the legs and pelvic region due to various factors such as obesity, prolonged sitting, pregnancy, patient with cardiovascular disorders, hip replacement or fractures as well as drug-induced thrombosis. The manufacturers of venous thromboembolism treatment devices such as thrombectomy devices, blood clot retrival devices are primarily focusing on new innovative technologies which can be used in conjuction with anti-coagulants and compression therapy.

venous thromboembolism treatment market snapshot

Venous Thromboembolism Treatment Market - Key Research Findings

  1. Global venous thromboembolism treatment market size in 2018 – Nearly US$ 1,200 Mn 

  1. The venous thromboembolism treatment market is expected to observe a CAGR of 4.0% over 2019-2029. 

  1. North America and Europe will reportedly continue to spearhead global market for venous thromboembolism treatment, through 2029. 

  • The presence of favorable reimbursement policies in the U.S. is one of the major factors contributing to the growth of the venous thromboembolism treatment market. 

  1. Asia Pacific holds a high growth potential for the venous thromboembolism treatment market 

  • Increasing healthcare awareness and increasing number of surgical procedures is expected to boost the growth of the venous thromboembolism treatment market. 

    venous thromboembolism treatment market analysis

Top 3 Factors Shaping the Venous Thromboembolism Treatment Market

  • Increasing Prevalence of Pulmonary Embolism

Increasing prevalence of pulmonary embolism disease is one of the major factors responsible for the growth of the venous thromboembolism treatment market. Several patients are at a very high risk of developing elevated levels of venous thromboembolism, and retrievable vena cava filters act as an aid to prevent the progression of fatal pulmonary embolism during bedside prophylactic treatment.

It is anticipated that the therapeutic application of vena cava filters will decrease globally due to several complications and risks associated when the device is not retrieved, and this is expected to accelerate the need for prophylactic filters for the treatment of such patient groups, which is another factor that is expected to boost the venous thromboembolism treatment market.

The number of surgical procedures is increasing globally, which is also expected to boost the growth of the venous thromboembolism treatment market. Venous thromboembolism devices enable physicians to work with greater flexibility and allow them to deliver drugs, fluids, and nutritional agents that are particularly useful for the treatment of these embolic patient groups, which is also expected to increase the overall growth of the venous thromboembolism treatment market.

  • Favourable Reimbursement Policies for Vena Cava Filter Procedures, Particularly in the U.S.

There are various favourable reimbursement policies, which can increase the overall growth of the venous thromboembolism treatment market. Several studies have reported that there is a strong correlation between the usage rate/adoption of prophylactic vena cava filters and a patient’s payer status. In 2012, a retrospective study on the usage of prophylactic filters carried out in U.S. found that there was 4.9% growth in the usage of prophylactic filters among patients with insurance coverage as compared to 2.7% in patient groups without any health insurance coverage.

The U.S. market is one of the largest revenue-generating regional markets for venous thromboembolism treatment. There are favourable reimbursement options for performing minimally invasive procedures in the country, which is expected to boost the growth of the venous thromboembolism treatment market. Moreover, the country offers physicians high incentives to use filters for prophylactic treatment. This factor is also likely to be responsible for the significant growth of the venous thromboembolism treatment market.  

  • Increasing Retrieval Rate of Vena Cava Filters

Vena cava filters are associated with serious medical complications post-surgical implantation. Hence, these devices need to be removed once the risk of pulmonary embolism reduces. In 2013, a report based on the quantitative risk-benefit profiling of retrieval vena cava filters reported that these filters should be replaced in a span of approximately one to two months, post-surgery.

As awareness about the possible risks involved in case of vena cava filters being left inside patients is growing, there has been a push in the venous thromboembolism treatment industry for developing advanced tracking systems for patient follow-up as well as to ensure filter removal in these patients once the risk of pulmonary embolism gets minimised. The increasing retrieval rate of vena cava filters is thus expected to increase the growth of the venous thromboembolism treatment market.

Venous Thromboembolism Treatment Market Structure Analysis

  • In the global venous thromboembolism treatment market, tier 1 companies hold a revenue share of more than 35%.

  • Key players in the venous thromboembolism treatment market focus on collaborations and partnerships to increase their product portfolio.

  • Leading players in the venous thromboembolism treatment market are also trying to launch some new products in the venous thromboembolism treatment market.

  • Some of the key strategies adopted by the manufacturers of venous thromboembolism treatment are playing a major role in the growth of the venous thromboembolism treatment market.

Market Set to Grow 1.5x between 2019 and 2029

The venous thromboembolism treatment market is likely to witness steady growth over the course of the forecast period. The increasing retrieval rate of vena cava filters and increasing number of vena cava surgical procedures are among factors driving the growth of the venous thromboembolism treatment market.

Emerging Countries Promise New Growth Opportunities

North America is expected to contribute the highest revenue share in the global venous thromboembolism treatment market in 2019. However, healthy growth is expected in developing countries, especially China, India, and South Korea. Among the emerging countries, India is likely to present significant growth opportunities of growth for stakeholders in the venous thromboembolism treatment market.

* This data is only a representation. Actual data may vary and will be available in report.

Emerging Countries Promise New Growth Opportunities
Emerging Countries Promise New Growth Opportunities
Emerging Countries Promise New Growth Opportunities
Emerging Countries Promise New Growth Opportunities
  • 2014
  • 2018
  • 2022
  • 2028
  • Arrow

The Broader Perspective

Stakeholders in the venous thromboembolism treatment market are adapting to the evolving requirements of the healthcare community and the patient pool. Manufacturers are mainly focusing on mergers and acquisitions. For example, in early 2016, Argon Medical fully acquired the option elite retrievable IVCF, cleaner rotational thrombectomy system, and UltraStream Chronic Hemodialysis Catheter. Moreover, in July 2017, Cardinal Health announced that it has completed the acquisition of Medtronic's patient care, deep vein thrombosis, and nutritional insufficiency businesses for US$6.1 billion.

Catheter-Directed Thrombolysis (CDT) Devices – This segment has a significant share in the market and is expected to grow at a higher rate during the forecast period

Percutaneous Thrombectomy Devices – This segment is likely to hold a remarkable share in the venous thromboembolism treatment market

Segmented Pneumatic Compression Pumps without Gradient – This segment is expected to show a significant growth rate in the venous thromboembolism treatment market

Deep Venous Thrombosis – This segment is expected to account for 70% of the total revenue in the overall market

Pulmonary Embolism – Pulmonary embolism is expected to witness a slower growth rate as compared to the deep venous thrombosis segment

Hospitals - Hospitals remain the top end-users with nearly 55% revenue share

Catheterisation Laboratories – Catheterisation laboratories are expected to grow at a significant rate

Ambulatory Surgical Centres – This segment is expected to witness a low share in the overall market

How Growth will Unfold

loreum

Catheter-Directed Thrombolysis (CDT) Devices | Percutaneous Thrombectomy Devices | Segmented Pneumatic Compression Pumps without Gradient

 Venous Thromboembolism Treatment Market  Venous Thromboembolism Treatment Market  Venous Thromboembolism Treatment Market

* This data is only a representation. Actual data may vary and will be available in report.

Click Here To Know How The Growth Will Unfold

Custom Market Research Services

FMI offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Overview

Venous Thromboembolism Treatment Market: Global Industry Analysis 2014-2018 & Opportunity Assessment 2019-2029

A recent market study published by FMI “Venous Thromboembolism Treatment Market: Global Industry Analysis 2014-2018 & Forecast 2019-2029” offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historic as well as current growth parameters of the venous thromboembolism treatment market, the growth prospects of the market are obtained with maximum precision.

Venous Thromboembolism Treatment Market Taxonomy

The global venous thromboembolism treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach in front of the reader.

By Product

  • Non-Segmented Pneumatic Compression Pumps
  • Segmented Pneumatic Compression Pumps without Gradient
  • Segmented Pneumatic Compression Pumps with Calibrated Gradient
  • Upper Pneumatic Compression Sleeves
  • Lower Pneumatic Compression Sleeves
  • Permanent Inferior Vena Cava Filters
  • Retrievable Inferior Vena Cava Filters
  • Embolectomy Balloon Catheters
  • Percutaneous Thrombectomy Devices
  • Catheter-Directed Thrombolysis (CDT) Devices

By Disease Indication

  • Deep Venous Thrombosis
  • Pulmonary Embolism

By End User

  • Hospitals
  • Catheterisation Laboratories
  • Ambulatory Surgical Centres

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

What's Included

The report commences with the executive summary of the venous thromboembolism treatment market, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the venous thromboembolism treatment market.

Readers can find the detailed taxonomy and the definition of the Venous Thromboembolism Treatment market in this chapter, which will help them understand the basic information about the venous thromboembolism treatment market. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the venous thromboembolism treatment market report.

The report provides key market trends that are expected to impact the market growth significantly during the forecast period. Detailed industry trends are provided in this section, along with key market development or product innovations.

This section includes the key inclusions of the report. It includes product adoption & usage analysis, reimbursement scenario, pipeline assessment & opportunity analysis, and manufactures strategies for market expansion.

This section explain the global market value analysis and forecast for the venous thromboembolism treatment market between the forecast periods of 2014-2029 is highlights in this section. This chapter includes the detailed analysis of the historical venous thromboembolism treatment market, along with an opportunity analysis of the future. Readers can also find the absolute opportunity for the current year (2019 – 2020), and an incremental opportunity for the forecast period (2019 – 2029).

This section highlights the average price of venous thromboembolism treatment. The pricing benchmark for manufacturer level pricing and distributor level pricing is analysed in this section.

This section explain the global market volume analysis and forecast for the Venous Thromboembolism Treatment market between the forecast periods of 2019-2029 is highlights in this section.

This chapter explains the key macro-economic factors that are expected to influence the growth of the Venous Thromboembolism Treatment market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the Venous Thromboembolism Treatment market. This chapter also highlights the key market dynamics of the venous thromboembolism treatment market, which include the drivers, restraints and trends. Moreover, readers will understand the key trends followed by the leading manufacturers in the venous thromboembolism treatment market.

Based on product type, the venous thromboembolism treatment market is segmented into non-segmented pneumatic compression pumps, segmented pneumatic compression pumps without gradient, segmented pneumatic compression pumps with calibrated gradient, upper pneumatic compression sleeves, lower pneumatic compression sleeves, permanent inferior vena cava filters, retrievable inferior vena cava filters, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (CDT) device  In this chapter, readers can find information about the key trends and developments in the venous thromboembolism treatment market and market attractiveness analysis based on the product type.

This chapter provides details about the venous thromboembolism treatment market on the basis of disease indication, and has been classified into deep venous thrombosis and pulmonary embolism. In this chapter, readers can understand the market attractive analysis based on disease indication

This chapter provides details about the venous thromboembolism treatment market on the basis of end user, and has been classified into hospitals, catheterization laboratories and ambulatory surgical centers. In this chapter, readers can understand the market attractive analysis based on end user.

This chapter explains how the venous thromboembolism treatment market will grow across various geographic regions, such as North America, Latin America, Europe, East Asia, South Asia, Oceania, the Middle East & Africa (MEA)

This chapter includes a detailed analysis of the growth of the North America venous thromboembolism treatment market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, regulations, and market growth based on the end users and countries in North America.

Readers can find detailed information about several factors, such as the pricing analysis and the regional trends, which are impacting the growth of the Latin America venous thromboembolism treatment market. This chapter also includes the growth prospects of the venous thromboembolism treatment market in the leading LATAM countries such as Brazil, Mexico, Argentina, and the Rest of Latin America.

Important growth prospects of the venous thromboembolism treatment market based on its end users in several countries, such as Germany, the UK, France, Spain, Italy, Russia, and the Rest of Europe, are included in this chapter.

India, Indonesia, Thailand , Malaysia are the leading countries in the South Asia region that are the prime subjects of assessment to obtain the growth prospects of the South Asia venous thromboembolism treatment market in this chapter. Readers can find detailed information about the growth parameters of the South Asia venous thromboembolism treatment market during the period 2019-2029.

This chapter highlights the growth of the venous thromboembolism treatment market in the East Asia by focusing on China, Japan and South Korea. This section also helps readers understand the key factors that are responsible for the growth of the venous thromboembolism treatment market in East Asia.

In this chapter, Australia and New Zealand are among the leading countries in the Oceania region, which are the prime subjects of assessment to obtain the growth prospects of the Oceania venous thromboembolism treatment market.

This chapter provides information about how the venous thromboembolism treatment market will grow in the major countries in the MEA region, such as GCC Countries, South Africa, Turkey, Northern Africa and the rest of MEA, during the forecast period 2019 - 2029.

In this chapter, readers can find a detailed information about the tier analysis and market concentration of the key players in the venous thromboembolism treatment market along with their market presence analysis by region and product portfolio.

In this chapter, readers can find a comprehensive list of all the leading stakeholders in the Venous Thromboembolism Treatment market, along with detailed information about each company, which includes the company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are  AngioDynamics, Boston Scientific Corp, Cardinal Health Inc., ArjoHuntleigh AB, BTG International Ltd., Stryker Corporation, DJO Global Inc., EKOS Corp, and Teleflex Inc. 

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the venous thromboembolism treatment report.

This chapter helps readers understand the research methodology followed to obtain the various conclusions as well as important qualitative and quantitative information about the venous thromboembolism treatment market.

How the research was conducted?

Primary Research

Primary research interview with Key Opinion Leaders and other participants were conducted for data collection and validation of the below information:

  • Prevalence of Pulmonary Embolism.
  • High Prevalence by Gender and Age-Group
  • Treatment Seeking Rate
  • Adoption of Venous Thromboembolism Treatment Devices as mode of treatment
  • Average Selling Price (US$) and Market Growth
  • Key Developments
  • Key Trends and Opportunities
  • Regional wise Dynamics
  • Reimbursement Landscape
  • Market Share Information
  • Key Brands
  • Competition & Key Vendor Strategies

Secondary Research

  • National Blood Clot Alliance
  • American Blood Clot Association
  • The American Lung Association
  • American Society of Hematology
  • National Heart Blood And Lung Institute
  • The Asia Pacific Vascular Society
  • American Heart Association
  • Annual Reports/SEC filings/Investor Presentations/Earning Call Transcript
  • Industry Journals

Primary Interview Splits

Primary Research Interview Splits

Venous Thromboembolism Treatment Market Reports - Table of Contents

To Learn More About our Comprehensive Perspective on Venous Thromboembolism Treatment Market,

Get in touch

Harish Tiwari

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Pranay Mhaisekar

Client Partner - Global Business Development

* indicates mandatory fields

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Methodology